Search Results
Found 1 results
510(k) Data Aggregation
(61 days)
Indicated for displaying images of the tracheobronchial tree to aid the physician in guiding endoscopic tools in the pulmonary tract. It does not make a diagnosis and is not an endoscopic tool.
The superDimension/Bronchus is a device that guides a bronchoscope and bronchial tool to a target in the bronchial tree on a path indicated by CT scan, and to visualize the interior of the tree and target
Here's an analysis of the provided text regarding the superDimension/Bronchus device, focusing on acceptance criteria and study details.
Based solely on the provided text, there is very limited information about specific acceptance criteria or a detailed clinical study demonstrating the device meets those criteria. The submission is a 510(k) summary, which often provides high-level information.
Here's a breakdown of what is available and what is missing:
1. Table of Acceptance Criteria and Reported Device Performance
| Acceptance Criteria (Explicitly Stated) | Reported Device Performance (as stated in the document) |
|---|---|
| Functional Safety Standards: Meets requirements of EN60601-1-2 | The superDimension/Bronchus "satisfies the requirements of EN60601-1-2." |
| Bench Testing: Extensive bench testing was performed. | The entire system "has had extensive bench testing." |
| Animal Tests: Animal tests were performed. | The superDimension/Bronchus "has had animal tests." |
| Clinical Evaluation: Clinical evaluation was performed. | The superDimension/Bronchus "has had... a clinical evaluation." |
| Intended Use: Device aids in guiding endoscopic tools. | The device "aids the physician in guiding endoscopic tools in the pulmonary tract." |
| Clinical Conclusion: Safe and effective for intended use. | The device is "safe and effective for its intended use." |
Critique: The document states that the device meets these criteria rather than defining specific thresholds or metrics for the criteria (e.g., "guiding accuracy must be within X mm"). This is common in 510(k) summaries which declare substantial equivalence rather than presenting detailed performance specifications.
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size: The document does not specify the sample size for the clinical evaluation (test set), nor does it break down the number of animal subjects. It only states "animal tests" and "a clinical evaluation."
- Data Provenance: The document doesn't specify the country of origin for the clinical data. It does state that superDimension Ltd. is located in Herzliya, Israel, which might imply the study was conducted there, but this is not explicitly stated for the clinical evaluation. It also doesn't explicitly state if the data was retrospective or prospective.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications
- Number of Experts: This information is not provided in the document.
- Qualifications of Experts: This information is not provided in the document.
4. Adjudication Method for the Test Set
- The adjudication method is not specified in the document.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done
- There is no mention of an MRMC comparative effectiveness study in the provided text.
- Therefore, no effect size for human readers improving with AI vs. without AI assistance can be determined from this document.
6. If a Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study was Done
- The device's intended use is to "aid the physician in guiding endoscopic tools," implying a human-in-the-loop system. The document does not describe any "standalone" performance evaluation of the algorithm without human intervention. Its stated purpose is as a guidance tool, not an autonomous diagnostic or procedural tool.
7. The Type of Ground Truth Used
- The document does not explicitly state the type of ground truth used for its "clinical evaluation" or "animal tests." Given the device's function as a guidance system for the tracheobronchial tree, potential ground truths could include:
- Direct visualization/localization: Confirmation of tool tip position relative to the target using a reference standard (e.g., fluoroscopy, repeat CT scan with markers, direct visual confirmation if accessible).
- Pathology/Biopsy results: If the guidance was for biopsy, the success of reaching a lesion later confirmed by pathology might be an indirect measure.
- Expert Consensus: Clinical assessment by experienced bronchoscopists regarding the accuracy and ease of guidance.
8. The Sample Size for the Training Set
- The document does not provide any information regarding a "training set" or its sample size. This is a pre-market submission for a device, not a detailed paper about algorithm development. It's likely that the product integrates software and algorithms, but the specifics of their development and training are not disclosed here.
9. How the Ground Truth for the Training Set Was Established
- Since there's no mention of a training set or its sample size, there's also no information on how its ground truth was established.
Summary of Missing Information:
This 510(k) summary provides a high-level overview focused on establishing substantial equivalence. It lacks the granular detail about clinical study design, specific performance metrics, ground truth establishment, or expert involvement that would typically be found in a detailed clinical report or peer-reviewed publication. The "Performance Data" section indicates that tests were done and standards met, but not the specifics of how these were measured or the quantitative results beyond a general conclusion of safety and effectiveness.
Ask a specific question about this device
Page 1 of 1